Silvercrest Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.43M | Sell |
20,338
-100
| -0.5% | -$27.1K | 0.04% | 411 |
|
|
2025
Q4 | $5.13M | Hold |
20,438
| – | – | 0.04% | 431 |
|
|
2025
Q3 | $5.87M | Sell |
20,438
-33
| -0.2% | -$8.84K | 0.04% | 408 |
|
|
2025
Q2 | $5.37M | Buy |
20,471
+52
| +0.3% | +$12.7K | 0.04% | 423 |
|
|
2025
Q1 | $4.75M | Sell |
20,419
-2,862
| -12% | -$695K | 0.03% | 412 |
|
|
2024
Q4 | $5.34M | Sell |
23,281
-215
| -0.9% | -$49.3K | 0.04% | 412 |
|
|
2024
Q3 | $5.25M | Sell |
23,496
-35
| -0.1% | -$7.69K | 0.04% | 379 |
|
|
2024
Q2 | $4.79M | Buy |
23,531
+42
| +0.2% | +$8.54K | 0.03% | 406 |
|
|
2024
Q1 | $5.13M | Sell |
23,489
-1,867
| -7% | -$411K | 0.03% | 387 |
|
|
2023
Q4 | $5.76M | Sell |
25,356
-666
| -3% | -$140K | 0.04% | 351 |
|
|
2023
Q3 | $5.23M | Sell |
26,022
-5,703
| -18% | -$1.2M | 0.04% | 353 |
|
|
2023
Q2 | $6.58M | Buy |
31,725
+398
| +1% | +$77.2K | 0.05% | 317 |
|
|
2023
Q1 | $6.17M | Sell |
31,327
-26,666
| -46% | -$5.49M | 0.05% | 305 |
|
|
2022
Q4 | $11.7M | Sell |
57,993
-179,138
| -76% | -$35M | 0.09% | 202 |
|
|
2022
Q3 | $41.7M | Sell |
237,131
-7,122
| -3% | -$1.46M | 0.34% | 103 |
|
|
2022
Q2 | $49.2M | Buy |
244,253
+2,134
| +0.9% | +$455K | 0.37% | 95 |
|
|
2022
Q1 | $54.8M | Sell |
242,119
-72,808
| -23% | -$17.1M | 0.36% | 95 |
|
|
2021
Q4 | $85M | Sell |
314,927
-398
| -0.1% | -$98.5K | 0.54% | 59 |
|
|
2021
Q3 | $76.2M | Sell |
315,325
-5,747
| -2% | -$1.45M | 0.51% | 65 |
|
|
2021
Q2 | $76.1M | Sell |
321,072
-210,437
| -40% | -$47.9M | 0.5% | 69 |
|
|
2021
Q1 | $116M | Buy |
531,509
+15,820
| +3% | +$3.17M | 0.79% | 20 |
|
|
2020
Q4 | $90.2M | Buy |
515,689
+20,238
| +4% | +$3.5M | 0.66% | 42 |
|
|
2020
Q3 | $80.1M | Sell |
495,451
-5,777
| -1% | -$916K | 0.69% | 39 |
|
|
2020
Q2 | $71.5M | Sell |
501,228
-11,386
| -2% | -$1.58M | 0.63% | 51 |
|
|
2020
Q1 | $55.7M | Sell |
512,614
-18,146
| -3% | -$2.61M | 0.6% | 61 |
|
|
2019
Q4 | $77.1M | Sell |
530,760
-1,700
| -0.3% | -$245K | 0.6% | 56 |
|
|
2019
Q3 | $76.8M | Buy |
532,460
+2,897
| +0.5% | +$423K | 0.63% | 52 |
|
|
2019
Q2 | $78.7M | Buy |
529,563
+34,238
| +7% | +$4.78M | 0.74% | 44 |
|
|
2019
Q1 | $65.1M | Buy |
495,325
+2,486
| +0.5% | +$306K | 0.64% | 58 |
|
|
2018
Q4 | $53.5M | Sell |
492,839
-14,364
| -3% | -$1.92M | 0.59% | 65 |
|
|
2018
Q3 | $75.7M | Buy |
507,203
+9,030
| +2% | +$1.37M | 0.69% | 45 |
|
|
2018
Q2 | $76.8M | Sell |
498,173
-36,713
| -7% | -$5.54M | 0.72% | 41 |
|
|
2018
Q1 | $74.3M | Sell |
534,886
-6,933
| -1% | -$1.02M | 0.72% | 43 |
|
|
2017
Q4 | $74.2M | Sell |
541,819
-830
| -0.2% | -$110K | 0.69% | 49 |
|
|
2017
Q3 | $70.4M | Sell |
542,649
-3,395
| -0.6% | -$453K | 0.7% | 49 |
|
|
2017
Q2 | $72.3M | Buy |
546,044
+3,605
| +0.7% | +$441K | 0.77% | 45 |
|
|
2017
Q1 | $66.9M | Buy |
542,439
+25,568
| +5% | +$3.03M | 0.72% | 49 |
|
|
2016
Q4 | $57M | Buy |
516,871
+34,750
| +7% | +$3.86M | 0.64% | 60 |
|
|
2016
Q3 | $56.9M | Buy |
482,121
+20,510
| +4% | +$2.42M | 0.68% | 52 |
|
|
2016
Q2 | $51.7M | Buy |
+461,611
| New | +$49.7M | 0.66% | 57 |
|
Other funds holding LH
VCM
VPM
Silvercrest Asset Management's LH Position: Q1 2026 in Review
Silvercrest Asset Management reduced its Labcorp (LH) stake by 0.49% in Q1 2026, selling an estimated $27.1K and leaving 20,338 shares worth $5.43M. The position accounts for 0.04% of the portfolio, ranked #411.
Silvercrest Asset Management first reported a position in LH in Q2 2016 and has held it in 40 quarters since. The position peaked at $116M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Silvercrest Asset Management held 20,338 shares of Labcorp worth $5.43M as of Q1 2026.
- Silvercrest Asset Management sold 100 Labcorp shares in Q1 2026, an estimated $27.1K.
- Labcorp made up 0.04% of Silvercrest Asset Management's portfolio in Q1 2026, its #411 holding.
- Silvercrest Asset Management first reported a position in Labcorp in Q2 2016 and has held it in 40 quarters since.
- Silvercrest Asset Management's Labcorp position peaked at $116M in Q1 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.